Ftse Mib
34.646,48
0,89%
DAX
18.762,26
0,44%
S&P 500
5.218,47
0,08%
NASDAQ
16.329,43
-0,10%
Bitcoin
61.056,58
-3,16%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Alpha Tau Medical Ltd (DRTS) Alpha Tau Medical Ltd (DRTS) Notizie

DRTS

Alpha Tau Medical (DRTS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DRTS
DataOraFonteTitoloSimboloCompagnia
06/05/202414:30GlobeNewswire Inc.Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in GlasgowNASDAQ:DRTSAlpha Tau Medical Ltd
01/05/202414:30GlobeNewswire Inc.Alpha Tau to Participate in May Investor ConferencesNASDAQ:DRTSAlpha Tau Medical Ltd
25/03/202413:50GlobeNewswire Inc.Alpha Tau to Present at the Jefferies Radiopharma Innovation SummitNASDAQ:DRTSAlpha Tau Medical Ltd
07/03/202422:13Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DRTSAlpha Tau Medical Ltd
07/03/202422:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
07/03/202422:01GlobeNewswire Inc.Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
26/02/202414:30GlobeNewswire Inc.Alpha Tau to Participate in Barclays 26th Annual Global Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
20/12/202315:15GlobeNewswire Inc.Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
18/12/202317:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DRTSAlpha Tau Medical Ltd
29/11/202314:30GlobeNewswire Inc.Alpha Tau to Participate in Sidoti Small-Cap ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
28/11/202314:30GlobeNewswire Inc.Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic CancerNASDAQ:DRTSAlpha Tau Medical Ltd
20/11/202314:30GlobeNewswire Inc.Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck CancerNASDAQ:DRTSAlpha Tau Medical Ltd
16/11/202322:30GlobeNewswire Inc.Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
30/10/202313:30GlobeNewswire Inc.Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing FacilityNASDAQ:DRTSAlpha Tau Medical Ltd
24/10/202315:00GlobeNewswire Inc.Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory BoardNASDAQ:DRTSAlpha Tau Medical Ltd
25/09/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DRTSAlpha Tau Medical Ltd
14/09/202314:30GlobeNewswire Inc.Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel’s Hadassah Medical CenterNASDAQ:DRTSAlpha Tau Medical Ltd
11/09/202322:16Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:DRTSAlpha Tau Medical Ltd
28/08/202322:02GlobeNewswire Inc.Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
17/08/202323:00GlobeNewswire Inc.Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRTNASDAQ:DRTSAlpha Tau Medical Ltd
09/06/202322:47Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:DRTSAlpha Tau Medical Ltd
06/06/202315:00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:DRTSAlpha Tau Medical Ltd
24/05/202322:01GlobeNewswire Inc.Alpha Tau Medical to Participate in June Investor ConferencesNASDAQ:DRTSAlpha Tau Medical Ltd
23/05/202322:01GlobeNewswire Inc.Alpha Tau Medical Announces First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
17/05/202322:30GlobeNewswire Inc.Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge UniversityNASDAQ:DRTSAlpha Tau Medical Ltd
11/05/202322:00GlobeNewswire Inc.Alpha Tau Announces the Publication of its US Multicenter Pilot Skin Cancer Trial Results in JAMA Network OpenNASDAQ:DRTSAlpha Tau Medical Ltd
03/05/202322:00GlobeNewswire Inc.Alpha Tau Medical to Present at Guggenheim Radiopharmaceuticals DayNASDAQ:DRTSAlpha Tau Medical Ltd
13/04/202314:24Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:DRTSAlpha Tau Medical Ltd
12/04/202312:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:DRTSAlpha Tau Medical Ltd
03/04/202315:10Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:DRTSAlpha Tau Medical Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DRTS

La tua Cronologia

BIT
ENEL
Enel
BIT
UCG
Unicredit
BIT
BFF
BFF Bank
BIT
LDO
Leonardo
BIT
ISP
Intesa Sanpaolo
BIT
IVG
Iveco Group NV
BIT
RACE
Ferrari NV
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
NEXI
Nexi S.p.A
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
MB
Mediobanca Banca di Cred...
BIT
PRY
Prysmian
BIT
G
Generali
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network